// App-Quantinova.ai

PO0789 : Thrombotic Microangiopathy (TMA) in a Patient with COVID-19

Researchers

Presenter

  • Flores Chang Bessy Suyin

Principal Investigators

  • Parikh Rushang

  • Wanchoo Rimda

  • Bijol Vanesa

  • Jhaveri KenarD

Medical Centers

  • 1Donald and Barbara Zucker School of Medicine at Hofstra/Northwell New York NY United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Thrombotic thrombocytopenic purpura

  • Thrombotic microangiopathy

  • Thrombocytopenia

  • Albuminuria

  • Coronavirus disease

  • Dyspnea

  • Anemia

  • Asthma

Biomarkers

  • Soluble Complement 5b-9

  • White Blood Cell

Drug/Treatment

  • Hydroxychloroquine

  • Tocilizumab

  • Eculizumab

  • Enoxaparin

  • Enoxaparin sodium

  • Anakinra

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved